|Bid||3.4600 x 900|
|Ask||4.4400 x 1200|
|Day's range||4.0900 - 4.8100|
|52-week range||3.4600 - 22.4600|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||34.23|
|Earnings date||19 Sept 2022 - 23 Sept 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.65|
DENVER, June 30, 2022 (GLOBE NEWSWIRE) -- InnovAge (NASDAQ: INNV), today announced the appointment of experienced health care executive James (“Jim”) Carlson to its Board of Directors, effective June 30, 2022. Carlson will serve as non-executive Chairman. “We are thrilled that Jim is stepping into the role of Chairman of InnovAge,” said Andrew Cavanna, outgoing Chairman of the Board. “Jim’s skill set, experience and reputation makes him an ideal fit to lead the InnovAge Board.” “I have known Jim
Investors need to pay close attention to InnovAge (INNV) stock based on the movements in the options market lately.
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...